LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹2.14 Cr | ₹-17 Cr | ₹9.21 Cr | ₹41 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of LASA SUPERGENERICS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2024 | ₹2.14 Cr |
| Mar2023 | ₹-17 Cr |
| Mar2022 | ₹9.21 Cr |
| Mar2021 | ₹41 Cr |
| Mar2020 | ₹14 Cr |
How is Cash Flow from Operating Activities of LASA SUPERGENERICS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2024 | ₹2.14 Cr | Positive | |
| Mar2023 | ₹-17 Cr | Negative | |
| Mar2022 | ₹9.21 Cr | -77.70 | |
| Mar2021 | ₹41 Cr | 203.24 | |
| Mar2020 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹39.4 Cr | -6.5% | 32.1% | -53.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,859.0 Cr | 4.2% | 5.3% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,618.0 Cr | 3.4% | 12.6% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,718.0 Cr | 2.2% | 4.1% | 28% | Stock Analytics | |
| CIPLA | ₹107,722.0 Cr | 2% | 11.5% | -13.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,081.0 Cr | -6.2% | 5.1% | 9.5% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -6.5% |
32.1% |
-53.9% |
| SENSEX | -0.4% |
7.1% |
-4% |
You may also like the below Video Courses